New drug combo targets Hard-to-Treat hepatitis d
NCT ID NCT05461170
Summary
This study is testing two experimental drugs, VIR-2218 and VIR-3434, in people with chronic hepatitis D virus infection. The goal is to see if these drugs can safely reduce the amount of virus in the blood and improve liver health. About 95 participants will receive different combinations of the drugs and be monitored for up to 192 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS D, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigative Site
Sofia, 1407, Bulgaria
-
Investigative Site
Sofia, 1431, Bulgaria
-
Investigative Site
Stara Zagora, 6003, Bulgaria
-
Investigative Site
Clichy, 92110, France
-
Investigative Site
Pessac, 33600, France
-
Investigative Site
Rennes, 35000, France
-
Investigative Site
Toulouse, 31000, France
-
Investigative Site
Frankfurt, 60596, Germany
-
Investigative Site
Hanover, 30625, Germany
-
Investigative Site
Tübingen, 72076, Germany
-
Investigative Site
Milan, 20122, Italy
-
Investigative Site
Pisa, 56124, Italy
-
Investigative Site
Chisinau, MD-2025, Moldova
-
Investigative Site
Rotterdam, 3015 GD, Netherlands
-
Investigative Site
Auckland, 1010, New Zealand
-
Investigative Site
Bucharest, 021105, Romania
-
Investigative Site
Birmingham, B15 2TT, United Kingdom
-
Investigative Site
London, E1 1RF, United Kingdom
-
Investigative Site
London, SE5 9RS, United Kingdom
-
Investigative Site
Manchester, M8 5RB, United Kingdom
Conditions
Explore the condition pages connected to this study.